Unlike IDH1-wildtype gliomas, IDH1 (R132H) mutations suppress PD-L1 expression through DNA hypermethylation, leading to a less immunosuppressive microenvironment (Figure 12) [23]. The gene discussed is IDH1; the disease is glioma.